Exploring the efficacy and safety of acupuncture versus sham acupuncture for diminished ovarian reserve: study protocol for a multicentre randomised controlled trial

被引:1
作者
Xiao, Qiwei [1 ]
Wu, Yumi [1 ]
Su, Chenchen [1 ]
Yang, Jie [2 ]
Wang, Jian [3 ]
Pei, Lixia [4 ]
Wang, Yang [5 ]
Hu, Jie [6 ]
Chen, Li [7 ]
Yang, Li [1 ]
Li, Jiashan [1 ]
Li, Weixin [1 ]
Gou, Minghui [1 ]
Feng, Yixuan [1 ]
Xu, Huanfang [1 ]
Fang, Yigong [1 ]
机构
[1] China Acad Chinese Med Sci CACMS, Inst Acupuncture & Moxibust, Beijing, Peoples R China
[2] Chengdu Xinan Gynecol Hosp, Chengdu, Peoples R China
[3] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Jinan, Peoples R China
[4] Jiangsu Prov Hosp Chinese Med, Nanjing, Peoples R China
[5] Guanganmen Hosp CACMS, Beijing, Peoples R China
[6] Wang Jing Hosp CACMS, Beijing, Peoples R China
[7] Nanjing Jinling Hosp, Nanjing, Peoples R China
关键词
gynaecology; complementary medicine; randomized controlled trial;
D O I
10.1136/bmjopen-2023-081098
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The therapeutic needs of women with diminished ovarian reserve (DOR), coupled with the increasing application of acupuncture in improving ovarian function, have highlighted the need to verify the efficacy and safety of acupuncture for DOR. This study aims to provide high-quality evidence by evaluating both ovarian reserve and in vitro fertilisation (IVF) outcomes.Methods and analysis A large-scale, multicentre, randomised controlled trial will be carried out across seven hospitals in China. 400 women with DOR will be randomised in a 1:1 ratio to an acupuncture group or a sham acupuncture group. Acupuncture or sham acupuncture will consist of 36 sessions per participant over 12 weeks. The primary outcome will be the change in antral follicle count (AFC) at week 12 from baseline. Secondary outcomes are AFC at week 24, the serum levels of basal follicle-stimulating hormone and anti-Mullerian hormone at weeks 12 and 24, the scores of the Self-Rating Anxiety Scale at weeks 12 and 24, clinical pregnancy rate, and IVF embryo transfer related outcomes. Any adverse events during treatment will be documented.Ethics and dissemination The study protocol has been approved by all the participating institutions. Written informed consent will be obtained prior to participant enrolment. The results of this study will be published in peer-reviewed publications.Trial registration number ChiCTR2200062295Protocol version V2.0-20220317
引用
收藏
页数:8
相关论文
共 24 条
[1]   A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept [J].
Alviggi, Carlo ;
Andersen, Claus Y. ;
Buehler, Klaus ;
Conforti, Alessandro ;
De Placido, Giuseppe ;
Esteves, Sandro C. ;
Fischer, Robert ;
Galliano, Daniela ;
Polyzos, Nikolaos P. ;
Sunkara, Sesh K. ;
Ubaldi, Filippo M. ;
Humaidan, Peter .
FERTILITY AND STERILITY, 2016, 105 (06) :1452-1453
[2]   Diminished ovarian reserve in recurrent pregnancy loss: a systematic review and meta-analysis [J].
Bunnewell, Sarah J. ;
Honess, Emma R. ;
Karia, Amar M. ;
Keay, Stephen D. ;
Al Wattar, Bassel H. ;
Quenby, Siobhan .
FERTILITY AND STERILITY, 2020, 113 (04) :818-+
[3]   Effect of Acupuncture on Premature Ovarian Failure: A Pilot Study [J].
Chen, Yingru ;
Fang, Yigong ;
Yang, Jinsheng ;
Wang, Fei ;
Wang, Yingying ;
Yang, Li .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
[4]  
Chow S.C., 2003, SAMPLE SIZE CALCULAT, DOI DOI 10.1201/9780203911341
[5]   Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System [J].
Devine, Kate ;
Mumford, Sunni L. ;
Wu, Mae ;
DeCherney, Alan H. ;
Hill, Micah J. ;
Propst, Anthony .
FERTILITY AND STERILITY, 2015, 104 (03) :612-+
[6]  
Expert Group of Consensus on Clinical Diagnosis & Management of Diminished Ovarian Reserve. Reproductive Endocrinology & Fertility Preservation Section of Chinese Society on Fertility Preservation under Chinese Preventive Medicine Association, 2022, J Reprod Med, V31, P425, DOI [10.3969/j.issn.1004-3845.2022.04.001, DOI 10.3969/J.ISSN.1004-3845.2022.04.001]
[7]  
Fan Su, 2022, Zhen Ci Yan Jiu, V47, P644, DOI 10.13702/j.1000-0607.20210330
[8]  
Fan Su, 2022, Zhongguo Zhen Jiu, V42, P237, DOI 10.13703/j.0255-2930.20201205-0003
[9]  
Fang Chen-Chen, 2019, Zhen Ci Yan Jiu, V44, P810, DOI 10.13702/j.1000-0607.180576
[10]   GRADE:: what is "quality of evidence" and why is it important to clinicians? [J].
Guyatt, Gordon H. ;
Oxman, Andrew D. ;
Vist, Gunn E. ;
Kunz, Regina ;
Falck-Ytter, Yngve ;
Schunemann, Holger .
BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7651) :995-999B